These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26253934)

  • 1. Elevated galanin may predict the risk of type 2 diabetes mellitus for development of Alzheimer's disease.
    Zhang Z; Fang P; Shi M; Zhu Y; Bo P
    Mech Ageing Dev; 2015 Sep; 150():20-6. PubMed ID: 26253934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential antidepressant and antidiabetic effects of galanin system.
    Fang P; Min W; Sun Y; Guo L; Shi M; Bo P; Zhang Z
    Pharmacol Biochem Behav; 2014 May; 120():82-7. PubMed ID: 24582894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory effects of galanin system on development of several age-related chronic diseases.
    Fang P; Yu M; Wan D; Zhang L; Han L; Shen Z; Shi M; Zhu Y; Zhang Z; Bo P
    Exp Gerontol; 2017 Sep; 95():88-97. PubMed ID: 28450241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathological interaction between diabetes mellitus and Alzheimer's disease].
    Takeda S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Nov; 32(5-6):239-44. PubMed ID: 23373309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A promising biomarker of elevated galanin level in hypothalamus for osteoporosis risk in type 2 diabetes mellitus.
    Fang P; She Y; Han L; Wan S; Shang W; Zhang Z; Min W
    Mech Ageing Dev; 2021 Mar; 194():111427. PubMed ID: 33383074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 2 diabetes mellitus as a disorder of galanin resistance.
    Fang P; Shi M; Zhu Y; Bo P; Zhang Z
    Exp Gerontol; 2016 Jan; 73():72-7. PubMed ID: 26585047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-sugar diets, type 2 diabetes and Alzheimer's disease.
    Moreira PI
    Curr Opin Clin Nutr Metab Care; 2013 Jul; 16(4):440-5. PubMed ID: 23657152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous peptides as risk markers to assess the development of insulin resistance.
    Fang P; Shi M; Yu M; Guo L; Bo P; Zhang Z
    Peptides; 2014 Jan; 51():9-14. PubMed ID: 24184593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetes mellitus and Alzheimer's disease].
    Salacz P; Csibri E
    Orv Hetil; 2011 Mar; 152(13):512-5. PubMed ID: 21398212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does insulin therapy for type 1 diabetes mellitus protect against Alzheimer's disease?
    Rdzak GM; Abdelghany O
    Pharmacotherapy; 2014 Dec; 34(12):1317-23. PubMed ID: 25280207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer's disease: studies in animal models.
    Calvo-Ochoa E; Arias C
    Diabetes Metab Res Rev; 2015 Jan; 31(1):1-13. PubMed ID: 24464982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the effect of inhibiting galanin in Alzheimer's disease induced in rats.
    Baraka A; ElGhotny S
    Eur J Pharmacol; 2010 Sep; 641(2-3):123-7. PubMed ID: 20639139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer disease and cognitive impairment associated with diabetes mellitus type 2: associations and a hypothesis.
    Domínguez RO; Pagano MA; Marschoff ER; González SE; Repetto MG; Serra JA
    Neurologia; 2014; 29(9):567-72. PubMed ID: 24140159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encephalopathies: the emerging diabetic complications.
    Sima AA
    Acta Diabetol; 2010 Dec; 47(4):279-93. PubMed ID: 20798963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation.
    Correia SC; Santos RX; Carvalho C; Cardoso S; Candeias E; Santos MS; Oliveira CR; Moreira PI
    Brain Res; 2012 Mar; 1441():64-78. PubMed ID: 22290178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-derived neurotrophic factor plasma levels: relationship with dementia and diabetes in the elderly population.
    Passaro A; Dalla Nora E; Morieri ML; Soavi C; Sanz JM; Zurlo A; Fellin R; Zuliani G
    J Gerontol A Biol Sci Med Sci; 2015 Mar; 70(3):294-302. PubMed ID: 24621946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vascular risk factors and Alzheimer's disease].
    Regalado Doña PJ; Azpiazu Artigas P; Sánchez Guerra ML; Almenar Monfort C
    Rev Esp Geriatr Gerontol; 2009; 44(2):98-105. PubMed ID: 19268394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The micron stroke hypothesis of Alzheimer's disease and dementia.
    Orehek AJ
    Med Hypotheses; 2012 May; 78(5):562-70. PubMed ID: 22381661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease.
    Rao AA; Sridhar GR; Das UN
    Med Hypotheses; 2007; 69(6):1272-6. PubMed ID: 17553629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease.
    Hölscher C
    Biochem Soc Trans; 2011 Aug; 39(4):891-7. PubMed ID: 21787319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.